Amarin Corporation plc

NasdaqGM:AMRN Stock Report

Market Cap: US$346.6m

Amarin Management

Management criteria checks 1/4

Amarin's CEO is Pat Holt, appointed in Jul 2023, has a tenure of less than a year. total yearly compensation is $2.51M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 0.077% of the company’s shares, worth $265.33K. The average tenure of the management team and the board of directors is 1.8 years and 1.1 years respectively.

Key information

Pat Holt

Chief executive officer

US$2.5m

Total compensation

CEO salary percentage12.2%
CEO tenureless than a year
CEO ownership0.08%
Management average tenure1.8yrs
Board average tenure1.1yrs

Recent management updates

Recent updates

Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Mar 12
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Amarin: Sarissa Is Giving Me Hope Again

Jan 15

Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Jan 03
Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Nov 19
Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

Sep 27
Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Jul 18
We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?

Nov 11
Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?

Amarin gains as activist Sarissa starts process for special meeting to replace some board members

Oct 11

Amarin down 21% on higher than normal daily volume

Aug 22

For Amarin, Something Wishful This Way Comes

Aug 14

Amarin Q2 2022 Earnings Preview

Aug 02

HLS Therapeutics gets reimbursement for Vascepa in Ontario

Jul 25

Amarin's Vazkepa medicine gets final guidance from UK body for reimbursement and use

Jul 13

Amarin extends losses after Stat report on cardiovascular therapy

Jun 30

Amarin: Alex Denner, Health Net, Statin Combo, And Signs Of Better Times

Apr 19

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Feb 23
Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Amarin: Revisiting Old Battles Lost

Feb 02

CEO Compensation Analysis

How has Pat Holt's remuneration changed compared to Amarin's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$3mUS$307k

-US$59m

Compensation vs Market: Pat's total compensation ($USD2.51M) is about average for companies of similar size in the US market ($USD2.15M).

Compensation vs Earnings: Insufficient data to compare Pat's compensation with company performance.


CEO

Pat Holt (50 yo)

less than a year

Tenure

US$2,512,126

Compensation

Mr. Patrick J. Holt, also known as Pat, is a President, CEO & Director at Amarin Corporation plc since July 18, 2023. He is an Independent Director of Hugel, Inc. since April 2022. He served as President o...


Leadership Team

NamePositionTenureCompensationOwnership
Patrick Holt
Presidentless than a yearUS$2.51m0.077%
$ 265.3k
Thomas Reilly
Executive VP1.8yrsUS$2.20m0.017%
$ 58.2k
Steven Ketchum
Executive VP8.2yrsUS$2.35m0.16%
$ 555.9k
Jonathan Provoost
Executive VPless than a yearUS$659.26kno data
Aaron Berg
Executive VP & President of U.S.no dataUS$2.45m0.15%
$ 534.4k
Jordan Zwick
Senior VP of Corporate Business Development & Investor Relations1.8yrsno datano data
Laurent Abuaf
President of Europe & Senior VPno datano datano data
Nabil Abadir
Chief Medical Officer of Global Medical Affairs1.9yrsno datano data
David Keenan
Executive VP of Technical Operations & President of Europe1.8yrsno datano data

1.8yrs

Average Tenure

51.5yo

Average Age

Experienced Management: AMRN's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Patrick Holt
Presidentless than a yearUS$2.51m0.077%
$ 265.3k
John Climax
Chairman of Scientific Advisory Board17.8yrsUS$39.00kno data
Jan Wallace
Member of Scientific Advisory Board17.8yrsno datano data
Mark Pierce
Member of the Scientific Advisory Board17.8yrsno datano data
Reid Patterson
Member of the Scientific Advisory Board17.8yrsno datano data
Louis Sterling
Independent Non-Executive Director1.1yrsUS$629.35k0.016%
$ 55.4k
Odysseas Kostas
Independent Non-Executive Chairperson of the Board1.1yrsUS$650.41k0%
$ 0
Diane Sullivan
Independent Non-Executive Director1.1yrsUS$630.83k0%
$ 0
Keith Horn
Independent Non-Executive Director1.1yrsUS$632.09k0%
$ 0
Mark DiPaolo
Independent Non-Executive Director1.1yrsUS$621.00k0%
$ 0
Patrice Bonfiglio
Independent Non-Executive Director1.1yrsUS$626.87k0%
$ 0
Paul Cohen
Independent Non-Executive Director1.1yrsUS$622.06k0%
$ 0

1.1yrs

Average Tenure

50.5yo

Average Age

Experienced Board: AMRN's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.